It is a pharma private limited company based in Andhra Pradesh, Telangana, India, established in 2003.
2003 | Andhra Pradesh, Telangana, India | ActiveCurevin Pharma Private Limited, a active private limited company, was established on 14 May 2003 in Andhra Pradesh, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24239TG2003PTC041002. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.43 M.
It upholds a compliant status. Its leadership includes Chelikani Sri Harsha (Director), Chelikani Rama Krishna (Managing Director), Chelikani Sandhya (Director). It holds ₹2.50 M open charges and ₹1.20 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 6-3-1099/1100/9/Asomajiguda Hyderabad, Andhra Pradesh, Telangana, 500029.
U24239TG2003PTC041002
041002
14 May 2003
₹1.00 M
₹0.43 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Curevin Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chelikani Sri Harsha | Director | 07 May 2018 | Current |
| Chelikani Rama Krishna | Managing Director | 14 May 2003 | Current |
| Chelikani Sandhya | Director | 14 May 2003 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Curevin Pharma Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 82.8% decrease. The company also saw a substantial fall in profitability, with a 58.84% decrease in profit. The company's net worth dipped by a decrease of 1.37%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Curevin Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,500,000.00
₹1,200,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Sep 2009 | Indian Bank | ₹2.50 M | Open |
| 11 Jun 2005 | State Bank Of Hyderabad | ₹1.20 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Curevin Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Curevin Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curevin Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Curevin Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Curevin Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Chelikani Sri Harsha was appointed as a Director was appointed as a Director on 07 May 2018 & has been associated with this company since 7 years 6 months . was recorded as a recent event.
A charge registered on 11 Jun 2005 via Charge ID 10074031 with State Bank Of Hyderabad was fully satisfied on 04 Dec 2009. was recorded as a recent event.
A charge with Indian Bank amounted to Rs. 2.50 M with Charge ID 10177953 was registered on 24 Sep 2009. was recorded as a recent event.
The activity A charge with State Bank Of Hyderabad amounted to Rs. 1.20 M with Charge ID 10074031 was registered on 11 Jun 2005. was completed.
The CIN of Curevin Pharma Private Limited is U24239TG2003PTC041002.
Curevin Pharma Private Limited is headquartered at 6-3-1099/1100/9/Asomajiguda Hyderabad, Andhra Pradesh, Telangana, 500029.
Curevin Pharma Private Limited was incorporated on 14 May 2003.
The current directors of Curevin Pharma Private Limited are
The primary industry of Curevin Pharma Private Limited is Trade.
Curevin Pharma Private Limited is unlisted.
The authorized capital of Curevin Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.43 M.
The compliance status of Curevin Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX